These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11877331)
1. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. MacInnes N; Handley SL Br J Pharmacol; 2002 Mar; 135(5):1227-34. PubMed ID: 11877331 [TBL] [Abstract][Full Text] [Related]
2. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Alemany R; Olmos G; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188 [TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219 [TBL] [Abstract][Full Text] [Related]
4. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney. King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560 [TBL] [Abstract][Full Text] [Related]
5. Potential serotonergic and noradrenergic involvement in the discriminative stimulus effects of the selective imidazoline I2-site ligand 2-BFI. MacInnes N; Handley SL Pharmacol Biochem Behav; 2003 May; 75(2):427-33. PubMed ID: 12873635 [TBL] [Abstract][Full Text] [Related]
6. Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway. Macinnes N; Duty S Br J Pharmacol; 2004 Dec; 143(8):952-9. PubMed ID: 15545290 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of imidazoline I2 binding sites in pig brain. Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401 [TBL] [Abstract][Full Text] [Related]
8. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B. McDonald GR; Olivieri A; Ramsay RR; Holt A Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472 [TBL] [Abstract][Full Text] [Related]
9. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine. Wiest SA; Steinberg MI Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963 [TBL] [Abstract][Full Text] [Related]
10. Relationship between imidazoline(2) sites and monoamine oxidase. Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610 [TBL] [Abstract][Full Text] [Related]
11. Effects of imidazoline I₂ receptor ligands on morphine- and tramadol-induced antinociception in rats. Thorn DA; Zhang Y; Peng BW; Winter JC; Li JX Eur J Pharmacol; 2011 Nov; 670(2-3):435-40. PubMed ID: 21970802 [TBL] [Abstract][Full Text] [Related]
12. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R; Olmos G; García-Sevilla JA Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats. Qiu Y; Zhang Y; Li JX Eur J Pharmacol; 2015 Feb; 749():133-41. PubMed ID: 25617792 [TBL] [Abstract][Full Text] [Related]
14. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine. Wiest SA; Steinberg MI Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892 [TBL] [Abstract][Full Text] [Related]
15. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035 [TBL] [Abstract][Full Text] [Related]
16. Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I₂ receptor ligands. Li JX; Zhang Y; Winter JC Eur J Pharmacol; 2011 Nov; 669(1-3):59-65. PubMed ID: 21867697 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain. Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus produced by the imidazoline I2 site ligand, 2 -BFI. Jordan S; Jackson HC; Nutt DJ; Handley SL J Psychopharmacol; 1996 Jan; 10(4):273-8. PubMed ID: 22302973 [TBL] [Abstract][Full Text] [Related]
19. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Lione LA; Nutt DJ; Hudson AL Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605 [TBL] [Abstract][Full Text] [Related]
20. Modulation of MAO activity by imidazoline and guanidine derivatives. Raasch W; Muhle H; Dominiak P Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]